Italy reconvenes CUD medical devices commission
This article was originally published in Clinica
Executive Summary
Italy has reconvened, until July 2010, the medical devices commission (CUD). The February 7 decree establishing its second renewal since 2002 has not changed its remit since taking on the "advisory" roles imposed in its first renewal in 2005. These feature the initiatives launched in 2007 to reclassify the devices available for use by the national health system (SSN), against new reference prices (see Clinica No 1286, p 3). The CUD's core competencies are to direct all national healthcare technology assessment, market regulation, product registration, surveillance and quality R&D activities.